![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its d... Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under pipeline are BDTX-189 and BDTX-1535. Show more
Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment...
CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of...
Initial Phase 2 data of BDTX-1535 in 2L/3L EGFRm NSCLC patients on track for Q3 2024Enrollment ongoing in Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLC; initial data...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.99 | 19.6819085487 | 5.03 | 6.28 | 4.87 | 532803 | 5.55063122 | CS |
4 | 0.65 | 12.104283054 | 5.37 | 6.28 | 4.1501 | 559229 | 4.93283101 | CS |
12 | 0.98 | 19.4444444444 | 5.04 | 7.66 | 4.1501 | 706196 | 5.50731254 | CS |
26 | 3.27 | 118.909090909 | 2.75 | 7.66 | 2.6 | 656749 | 5.03430663 | CS |
52 | 1.1 | 22.3577235772 | 4.92 | 7.66 | 1.62 | 596386 | 4.09699116 | CS |
156 | -3.6 | -37.422037422 | 9.62 | 10.5 | 1.18 | 681345 | 5.07947772 | CS |
260 | -26.98 | -81.7575757576 | 33 | 46.25 | 1.18 | 575701 | 9.15670042 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions